SG/PUT/PFIZER INC/25/0.1/20.06.25 | Real-time Bid/Ask 10:35:32 2024-07-01 EDT | ||
| 0.15 EUR / 0.16 EUR | -3.13% |
|
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
PFIZER, INC.
Latest news about PFIZER, INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-07-01 | 0.15 | -6.25% |
| 24-06-28 | 0.16 | -5.88% |
| 24-06-27 | 0.17 | +13.33% |
| 24-06-26 | 0.15 | +7.14% |
| 24-06-25 | 0.14 | -12.50% |
Delayed Quote Börse Stuttgart
Last update July 01, 2024 at 02:38 am
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | PUT |
| Underlying | PFIZER, INC. |
| Issuer | 
Société Générale
|
| WKN | SY03NW |
| ISIN | DE000SY03NW8 |
| Date issued | 2024-05-30 |
| Strike | 25 $ |
| Maturity | 2025-06-20 (354 Days) |
| Parity | 10 : 1 |
| Emission price | 0.17 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 0.18 € |
|---|---|
| Lowest since issue | 0.12 € |
| Spread | 0.01 € |
| Spread % | 6.67% |
Company Profile
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows:
- primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.;
- specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.;
- oncology products (12.1%);
- other (1.3%).
At the end of 2022, the group had more than 35 manufacturing sites worldwide.
Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
Consensus: Pfizer, Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
27.98
USD
Average target price
31.92
USD
Spread / Average Target
+14.07%
- Stock Market
- Warrants
- Warrant
